Objective There is currently no consensus
about managing upper airway obstruction (UAO) in infants with Robin
sequence (RS), in terms of treatment efficacy or clinical outcomes. This
study describes UAO management in UK/Ireland, and explores relationships
between patient characteristics, UAO management, and clinical outcomes
in the first two years of life. Methods Active surveillance of
RS throughout UK/Ireland via the British Paediatric Surveillance Unit
and nationally commissioned cleft services. Clinical data were collected
at initial notification and 12-month follow-up. Results 173
infants with RS were identified, of which 47% had additional congenital
anomalies or an underlying syndrome (non-isolated RS). Two-thirds (
n=119) required an airway intervention other than prone
positioning: non-surgical in 84% and surgical (tracheostomy) in 16%.
Nasopharyngeal airway (NPA) was the most common intervention, used in
83% ( n=99) for median 90 days (IQR 136). Surgical UAO
management was associated with prolonged hospital admission, higher
prevalence of neurodevelopmental delay (NDD), lower weight-for-age
z-scores, and delayed oral feeding. These findings were not attributable
to a higher prevalence of non-isolated RS in this group. Although more
commonly associated with non-isolated RS, growth faltering was also
identified in 48%, and NDD in 18%, of isolated RS cases.
Conclusions In UK/Ireland, most infants with RS are managed
with NPA and tracheostomy is reserved for refractory severe UAO.
Clinical outcomes and duration of use indicate that NPA is a safe and
feasible first-line approach to UAO. Longitudinal assessment of
neurodevelopment and growth is imperative, including in children with
isolated RS. Current variations in practice reinforce the need for
evidence-based treatment guidelines.